Eileen Wu
Impact in
- Toxicology top 2%
- Pharmacovigilance and Adverse Drug Reactions
- Genetics top 10%
- Coagulation, Bradykinin, Polyphosphates, and Angioedema
Papers in
-
- Pharmacovigilance and Adverse Drug Reactions 8
-
- Pharmaceutical studies and practices 4
- Co-authors
- Cindy Kortepeter (7 shared papers)Sengwee Toh (2 shared papers)Azadeh Shoaibi (2 shared papers)Marsha E. Reichman (2 shared papers)Monika Houstoun (2 shared papers)Mark Levenson (2 shared papers)Gwen L. Zornberg (2 shared papers)Mary Southworth (2 shared papers)
- Journals
- Drug Safety (3 papers)Clinical Pharmacology & Therapeutics (2 papers)Colorectal Disease (2 papers)Journal of Drug Issues (1 paper)Journal of the American Pharmacists Association (1 paper)
- Partner nations
- United StatesUnited KingdomJapan
In The Last Decade
Eileen Wu
22 papers receiving 366 citations
Peers
Comparison fields: 5 of 73
- Toxicology 95
- Genetics 91
- Statistics and Probability 51
- Geriatrics and Gerontology 15
- Gastroenterology 19
Countries citing papers authored by Eileen Wu
This map shows the geographic impact of Eileen Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eileen Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eileen Wu more than expected).
Fields of papers citing papers by Eileen Wu
This network shows the impact of papers produced by Eileen Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eileen Wu. The network helps show where Eileen Wu may publish in the future.
Co-authors
The 25 scholars most cited alongside Eileen Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 161 | |
| 2 | 2017 | 32 | |
| 3 | 2005 | 20 | |
| 4 | 2022 | 17 | |
| 5 | 2020 | 16 | |
| 6 | 2018 | 16 | |
| 7 | 2018 | 15 | |
| 8 | 2018 | 14 | |
| 9 | 2012 | 13 | |
| 10 | 2012 | 12 | |
| 11 | 2015 | 10 | |
| 12 | 2021 | 8 | |
| 13 | 2022 | 8 | |
| 14 | 1988 | 8 | |
| 15 | 2016 | 7 | |
| 16 | 2019 | 7 | |
| 17 | 2023 | 6 | |
| 18 | 2022 | 3 | |
| 19 | 2010 | 2 | |
| 20 | 2023 | 1 |
About Eileen Wu
Eileen Wu is a scholar working on Toxicology, Pediatrics, Perinatology and Child Health, Economics and Econometrics, Statistics and Probability and Surgery, having authored 23 papers that have together received 378 indexed citations. Recurring topics across this work include Pharmacovigilance and Adverse Drug Reactions (8 papers), Pharmaceutical studies and practices (4 papers), Statistical Methods in Clinical Trials (4 papers), Ethics in Clinical Research (3 papers), Pharmaceutical Economics and Policy (3 papers), Computational Drug Discovery Methods (2 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (2 papers) and Biomedical Text Mining and Ontologies (2 papers). The work is most often cited by research in Toxicology (95 citations), Genetics (91 citations), Statistics and Probability (51 citations), Geriatrics and Gerontology (15 citations) and Gastroenterology (19 citations). Eileen Wu has collaborated with scholars based in United States, United Kingdom and Japan. Frequent co-authors include Cindy Kortepeter, Sengwee Toh, Azadeh Shoaibi, Marsha E. Reichman, Monika Houstoun, Mark Levenson, Gwen L. Zornberg, Mary Southworth, Carolyn McCloskey and Sean Hennessy. Their work appears in journals such as Drug Safety, Clinical Pharmacology & Therapeutics, Colorectal Disease, Journal of Drug Issues and Journal of the American Pharmacists Association.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.